iTRAQ proteomic identification of pVHL-dependent and -independent targets of Egln1 prolyl hydroxylase knockdown in renal carcinoma cells

Advances in Enzyme Regulation

Volumn 49, Issue 1, 2009, Pages 121-132

  Haffey, Wendy D ^a   Mikhaylova, Olga ^a   Meller, Jarek ^a   Yi, Ying ^a   Greis, Kenneth D ^a   Czyzyk Krzeska, Maria F ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EGLN1 PROTEIN, HUMAN; ISOENZYME; PEPTIDE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN SUBUNIT; RNA POLYMERASE II; VON HIPPEL LINDAU PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL LINE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; KIDNEY CARCINOMA; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PROTEOMICS;

AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, RENAL CELL; CELL LINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PEPTIDES; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN SUBUNITS; PROTEOMICS; RNA POLYMERASE II; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 66449120333     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2008.12.004     Document Type: Article

References (40)

1. Allen S., Abuzenadah A.M., Hinks J., Blagg J.L., Gursel T., Ingerslev J., et al. A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion. Blood 15 (2000) 560-568
2. Appelhoff R.J., Tian Y.-M., Raval R.R., Turley H., Harris A.L., Pugh C.W., et al. Differential function of the prolyl hydroxylase PHD1, PHD2 and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279 (2004) 38458-38465
3. Aragones J., Schneider M., Van Geyte K., Fraisl P., Dresselaers T., Mazzone M., et al. Deficiency or inhibition of oxygen sensor PHD1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40 (2008) 170-180
4. Asanuma K., Yanagida-Asanuma E., Faul C., Tomino Y., Kim K., and Mundel P. Synaptopodin orchestrates actin organization and cell motility via regulation of RhA signaling. Nat Cell Biol 8 (2006) 485-491
5. Berra E., Benizri E., Ginouves A., Volmat V., Roux D., and Pouyssegur J. HIF prolyl hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1 alpha in normoxia. EMBO J 22 (2003) 4082-4090
6. Brown K.M., and Gilmartin G.M. A mechanism for the regulation of pre-mRNA 3′ processing by human cleavage factor Im. Mol Cell 12 (2003) 1467-1476
7. Burnelle J.K., Bell E.L., Quaseda N.M., Vercautern K., Tiranti V., Zeviani M., et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 1 (2005) 409-414
8. Canela N., Rodriguez-Vilarrupla A., Estanyol J.M., Diaz C., Pujol M.J., Agell N., et al. The SET protein regulates G2/M transition by modulating cyclin B-dpenendent kinase 1 activity. J Biol Chem 278 (2003) 1158-1164
9. Carpenter B., Hill K.J., Charalambous M., Wagner K.J., Lahiri D., James D.I., et al. BASP1 is a transcriptional corepressor for the Wilms' tumor suppressor protein WT1. Mol Cell Biol 2004 24 (2004) 537-549
10. Chevrollier A., Loiseau D., Chabi B., Renier G., Douay O., Malthiery Y., et al. ANT2 isoform is required for cancer glycolysis. J Bioenerg Biomembr 37 (2005) 307-316
11. Cummins E.P., Berra E., Comerford K.M., Ginouves A., Fitzgerald K.T., Seeballuck F., et al. Prolyl hydroxylase-1 negatively regulates IkB kinase-b, giving insight into hypoxia-induced NF-kB activity. Proc Natl Acad Sci U S A 103 (2006) 18154-18159
12. Dissemond J., Busch M., Kothen T., Mors J., Weimann T.K., Lindeke A., et al. Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma. Cancer Lett 203 (2004) 225-231
13. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
14. Ewing R.M., Chu P., Elisma F., Li H., Taylor P., Climie S., et al. Mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 3 (2007) 89
15. Fong G.-H., and Takeda K. Role of regulation of prolyl hydroxylase domain proteins. Cell Death Diff 15 (2008) 635-641
16. Frei C., and Edgar B.A. Drosophila cyclin D/Cdk4 requires HIf-1 prolyl hydroxylase to drive cell growth. Dev Cell 6 (2004) 241-251
17. Gamble M.J., and Fisher R.P. SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery. Nat Struct Mol Biol 14 (2007) 548-555
18. Gerald D., Berra E., Frapart Y.M., Chan D.A., Giaccia A.J., Mansuy D., et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118 (2004) 781-794
19. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17 (1999) 994-999
20. Haiman C.A., Setiawan V.W., Xia L.Y., Le Marchand L., Ingles S.A., Ursin G., et al. A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African Americans. Cancer Res 67 (2007) 565-568
21. Horke S., Witte I., Wigenbus P., Kruger M., Strand D., and Forstermann U. Paraoxanase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 17 (2007) 2055-2064
22. Huizinga E.G., Tsuji S., Romijn R.A., Schiphorst M.E., de Groot P.G., Sixman J.J., et al. Structure of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 297 (2002) 1176-1179
23. 2 sensing. Science 292 (2001) 464-468
24. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
25. Kaelin Jr. W.G. Proline hydroxylation and gene expression. Annu Rev Biochem 74 (2005) 115-128
26. Kotik-Kogan O., Valentine E.R., Sanfelice D., Conte M.R., and Curry S. Structural analysis reveals conformational plasticity in the recognition of RNA 3′ ends by the human La protein. Structure 16 (2008) 852-862
27. Kuznetsova A.V., Meller J., Schnell P.O., Nash J.A., Ignacak M.L., Sanchez Y., et al. von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc Natl Acad Sci U S A 100 (2003) 2706-2711
28. Lee S., Nakamura E., Yang H., Wei W., Linggi M.S., Sajan M.P., et al. Neuronal apoptosis linked to Egln3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8 (2005) 155-167
29. Mikhaylova O., Ignacak M.L., Barankiewicz T.J., Harbaugh S.V., Yi Y., Maxwell P.H., et al. The von Hippel-Lindau tumor suppressor protein and Egl 9-type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Mol Cell Biol 28 (2008) 2701-2717
30. Nakayama K., Frew I.J., Hagensen M., Skals M., Habelhah H., Bohumik A., et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell 117 (2004) 941-952
31. Rizvi S.M., Mancino L., Thammavongsa V., Cantley R.L., and Raghavan M. A polypeptide binding conformation of calreticulin is induced by heat shock, calcium depletion or by deletion of the C-terminal acidic region. Mol Cell 15 (2004) 913-923
32. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteom 3 (2004) 1154-1169
33. Sadasivan B., Lehner P.J., Spies T., and Cresswell P. Role of calreticulin and a novel glycoprotein, tapsin, in the interaction of MHC class I molecules with ATP. Immunity 5 (1996) 103-114
34. Timchenko L.T., Iakova P., Welm A.L., Cai Z.J., and Timchenko N.A. Calreticulin interacts with C/EBPalpha and C/EBPbeta mRNAs and represses translation of C/EBP proteins. Mol Cell Biol 22 (2002) 7242-7257
35. Tsuchiya H., Iseda T., and Hino O. Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product. Cancer Res 56 (1996) 2881-2885
36. Van der Flier A., Kuikman I., Kramer D., Geerts D., Kreft M., Takafuta T., et al. Different splice variants of filamin B affect myogenesis, subcellular distribution, and determine binding of integrin (beta) subunits. J. Cell Biol 156 (2002) 361-376
37. Wang X., Liu L., Montagna C., Ried T., and Deng C.X. Haploin sufficiency of PARP1 accelerates Brca1-associated centrosome amplification, telomere shortening, genetic instability, apoptosis, and embryonic lethality. Cell Death Diff 14 (2007) 924-931
38. Xian Z.H., Zhang S.H., Cong W.M., Yan H.X., Wang K., and Wu M.C. Expression of aspartyl beta hydroxylase and its clinicopathological significance in hepatocellular carcinoma. Mod Pathol 19 (2006) 280-286
39. Yang Z., Cheng W., Hong L., Chen W., Wang Y., Lin S., et al. Adenine nucleotide (ADP/ATP) translocase 3 participates in the tumor necrosis factor induced apoptosis of MCF-7 cells. Mol Cell Biol 18 (2007) 4681-4689
40. Yoshio T., Morita T., Kimura Y., Tsujii M., Hayashi N., and Sobue K. Caldesmon suppresses cancer cell invasion by regulating podosome/invaopodium formation. FEBS Lett 581 (2007) 3777-3782